News | June 04, 2008

MRI Annual Procedure Growth Slows to 3 Percent

June 5, 2008 – There was a 14 percent increase in MRI procedures from 2003 to 2007, for an average annual rate of 3 percent, representing a slowdown in procedure growth compared to the beginning of the decade, when the average annual growth rate from 1999 to 2003 was about 15 percent, according to IMV’s recent census of MRI sites in the U.S.

The census showed an estimated 27.5 million MRI procedures were performed at 7,195 sites in 2007, increasing from 24.2 million in 2003.

The census also found that early 1,100 hospitals are using mobile MRI services to provide their MRI capability. In 2007, the two highest volume categories were “spine” with 26 percent and “brain” with 25 percent of the MRI procedures and Magnetic Resonance Angiography (MRAs) comprise 9 percent of the total MRI procedure mix.
MRI breast imaging studies have doubled since 2003 from 314,000 to 645,000 procedures, but still account for only 2 percent of the total number of MRI procedures. Of the 2007 MRI procedures, 43 percent used a contrast agent as part of the imaging procedure.

IMV's 2007 MRI Market Summary Report describes trends in procedure utilization, the MRI installed base and purchase plans, workstations, contrast media utilization and budgets, power injectors and site operations characteristics. The report also covers adoption trends of new procedures such as echo planar imaging, MR spectroscopy, cardiac-approved MRI, functional MRI and multichannel MRI.

The data source for this report is IMV’s 2006/07 MRI Census Database, which provides comprehensive profiles of hospital and nonhospital MRI sites in the U.S. The database can be licensed by qualified subscribers and includes contact and site-specific information.

For more information: www.imvinfo.com

Related Content

International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
Ann Arbor Startup Launches Augmented Reality MRI Simulator
Technology | Virtual and Augmented Reality | June 04, 2019
SpellBound, an Ann Arbor startup specializing in augmented reality (AR) tools for children in hospitals, has officially...

Photo courtesy of Philips Healthcare

Feature | Radiology Business | May 31, 2019 | By Arjen Radder
Change is a consistent theme in our world today, no matter where you look.
MRI Metal Artifact Reduction Poses Minimal Thermal Risk to Hip Arthroplasty Implants
News | Magnetic Resonance Imaging (MRI) | May 23, 2019
Clinical metal artifact reduction sequence (MARS) magnetic resonance imaging (MRI) protocols at 3 Tesla (3T) on hip...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...